362 results on '"Vlachoyiannopoulos, Panayiotis G."'
Search Results
2. Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells
3. Computational Methods for Anticancer Drug Discovery; The MCT4 Paradigm
4. NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease.
5. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
6. Basic Immunology
7. Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study
8. A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
9. COVID-19 infection among autoimmune rheumatic disease patients: Data from an observational study and literature review
10. Helicobacter pylori Eradication Reverses DNA Damage Response Pathway but Not Senescence in Human Gastric Epithelium
11. Medications, Therapeutic Modalities, and Regimens Used in the Management of Rheumatic Diseases
12. Rheumatic Manifestations: A Compilation
13. Rheumatic Disorders Associated with Metabolic, Endocrine, and Hematological Diseases
14. Bone, Cartilage, and Soft Tissue Disorders
15. The Skin, the Eyes, and the Ears in Rheumatic Diseases
16. Sjögren’s Syndrome, IgG4-Related Disorders
17. Autoinflammatory Syndromes
18. Vasculitides and Related Diseases
19. Inflammatory Muscle Disease
20. Systemic Sclerosis
21. Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Mixed Connective Tissue Disease
22. Inflammatory Arthritides
23. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
24. Basic Immunology
25. Autoimmune Rheumatic Disorders: Pathogenetic and Laboratory Aspects
26. Basic Immunology
27. Natural Proteins Involved in Antiphospholipid Syndrome
28. NMR-based metabolomics in giant cell arteritis and polymyalgia rheumatica sequential sera differentiates active and inactive disease
29. Tocilizumab improves clinical outcome in patients with active corticosteroid-resistant moderate-to-severe Graves’ orbitopathy: an observational study
30. Treatment of rheumatoid arthritis: Unraveling the conundrum
31. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome
32. Central nervous system involvement in patients with granulomatosis with polyangiitis: a single-center retrospective study
33. What are the Target Cells and Receptors that are Recognized by Antiphospholipid Antibodies?
34. Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine
35. The Role of the Akt Signaling Pathway in Sjögren’s Syndrome
36. Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
37. Rheumatology in Questions
38. Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and/or antiphospholipid syndrome: A 10-year follow-up study
39. Mapping and predicting mortality from systemic sclerosis
40. 08.35 Thrombospondin-1 is elevated in the plasma of patients with antiphospholipid syndrome and is correlated with free active tgf-b1 levels, il-1b and il-17a
41. 02.02 Pharmaceutical disruption of B2GPI CXCL4 complex using computationally designed oligopeptides
42. Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases.
43. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases
44. Factor XI is a substrate for oxidoreductases: Enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis
45. Subgroups of Sjögren syndrome patients according to serological profiles
46. Detection of Autoantibodies to Extractable Cellular Antigens
47. Late and booster anti‐SARS‐CoV ‐2 humoral responses in nonresponder vaccinated patients with rheumatic diseases receiving mycophenolate or rituximab: comment on the article by XXX et al
48. Incidence of autoantibodies related to systemic autoimmunity in patients with severe COVID-19 admitted to the intensive care unit
49. β2 Glycoprotein I (β2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome
50. A novel mechanism of thrombosis in antiphospholipid antibody syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.